Jesse M. Tettero

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Alberto Hernández‐Sánchez, Teresa González, Marta Sobas et al. · Leukemia · 2024 · 22 citations · Full text

Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial

Lok Lam Ngai, Diana Hanekamp, Fleur Janssen et al. · Blood · 2023 · 16 citations · Full text

Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry

Jesse M. Tettero, Naveen Dakappagari, Maaike E. Heidinga et al. · Cytometry Part B Clinical Cytometry · 2023 · 16 citations · Full text

Machine Learning Allows the Identification of New Co-Mutational Patterns with Prognostic Implications in <i>NPM1</i> Mutated AML - Results of the European Harmony Alliance

Alberto Hernández‐Sánchez, Ángela Villaverde Ramiro, Eric Sträng et al. · Blood · 2022 · 14 citations